Cepheid announced it has received clearance from the Food and Drug Administration (FDA) to market Xpert Norovirus, an in vitro diagnostic test for identification and differentiation of Noroviruses ...
Co announces it received clearance from the FDA to market its Xpert M.R.S.A test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus. "Currently ...
In an HIV-positive population, the Xpert MTB/RIF Ultra assay detected tuberculous meningitis with higher sensitivity than the older Xpert assay and a mycobacterial growth indicator tube culture, ...
Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were ...
Co announces it received clearance from the FDA to market its Xpert EV test, which runs on the GeneXpert System, for the presumptive qualitative detection of enterovirus RNA in cerebrospinal fluid as ...
SUNNYVALE, Calif., Oct. 28, 2025 /PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new ...
Evaluation of the Xpert MTB/RIF Test for the Diagnosis of Childhood Pulmonary Tuberculosis in Uganda
The study was approved by the School of Medicine Research and Ethics committee of Makerere University College of Health Sciences (# REC REF 2011–005). The children were enrolled upon provision of ...
SUNNYVALE, Calif., May 29, 2019 /PRNewswire/ -- Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for testing throat and rectal specimens with its ...
The Xpert MTB/XDR test developed by the Foundation for Innovative New Diagnostics (FIND) and Cepheid Inc. quickly indicates whether a patient has a dangerous – and rapidly increasing – strain of ...
SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Evaluation of the Xpert MTB/RIF Test for the Diagnosis of Childhood Pulmonary Tuberculosis in Uganda
Background The diagnosis of childhood tuberculosis remains a challenge worldwide. The Xpert MTB/RIF test, a rapid mycobacteria tuberculosis diagnostic tool, was recommended for use in children based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback